Vaccine Research Center at NIAID (NIH)

Vaccine Research Center at NIAID (NIH)

The Vaccine Research Center at the National Institute of Allergy and Infectious Disease (NIAID) is the part of the U.S. National Institutes of Health (NIH) which researches infectious diseases and their prevention.

The Dale and Betty Bumpers Vaccine Research Center (VRC) is part of the National Institute of Allergy and Infectious Disease (NIAID), which is in turn a branch of the National Institutes of Health (NIH). The VRC was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases.

The VRC was established under Bill Clinton's presidential administration as part of the U.S. response to the HIV/AIDS epidemic.

Research efforts

The Viral Research Center undertakes research into established and emerging infectious diseases and helps to fund development of vaccines for those diseases.

The VRC's primary areas of research and development include HIV vaccine research, Ebola vaccine research, and research into vaccines for both seasonal influenza and influenza strains with the potential to cause pandemics (ex. H1N1 and H5N1).

SARS-CoV-2 vaccine research

The Viral Research Center and the broader National Institute of Allergy and Infectious Disease (NIAID) organization have collaborated with Moderna Therapeutics on the development of mRNA-1273, an mRNA-based vaccine candidate for SARS-CoV-2, the virus which causes COVID-19.

Phase I clinical trials of mRNA-1273 started on March 3, 2020 and are expected to conclude on June 1, 2021.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Meso Scale Diagnostics, LLC
December 1, 2020
www.prnewswire.com:443
/PRNewswire/ -- Meso Scale Diagnostics, LLC. (MSD) today announced the commercial release of its V-PLEX® Serology Panels for COVID-19. The release includes the...
Meso Scale Diagnostics, LLC
December 1, 2020
www.prnewswire.com:443
/PRNewswire/ -- Meso Scale Diagnostics, LLC. (MSD) today announced the commercial release of its V-PLEX® Serology Panels for COVID-19. The release includes the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.